Amoxicillin Dosing Guidelines
Standard Adult Dosing
For most adult infections, amoxicillin should be dosed at 500 mg three times daily or 875 mg twice daily, with the FDA-approved range of 750–1750 mg/day divided every 8–12 hours. 1
- For acute bacterial sinusitis in adults, the standard dose is 500 mg twice daily for 7–10 days. 2
- For community-acquired pneumonia and more severe respiratory infections, higher doses may be warranted based on local resistance patterns. 2
- The maximum adult dose should not exceed 4000 mg per day regardless of indication. 3
Standard Pediatric Dosing (Children >3 Months)
For most pediatric bacterial infections, amoxicillin should be dosed at 45 mg/kg/day divided every 12 hours (twice daily) for mild-to-moderate infections. 3, 4
Indication-Specific Pediatric Dosing:
- Community-acquired pneumonia (mild-to-moderate): 45 mg/kg/day in 2 divided doses 2, 3
- Community-acquired pneumonia (severe) or high pneumococcal resistance areas: 90 mg/kg/day in 2 divided doses (maximum 4 g/day) 2, 3
- Group A Streptococcal pharyngitis: 50–75 mg/kg/day in 2 divided doses for 10 days (maximum 1000 mg per dose) 2, 3
- Acute otitis media (uncomplicated): 45 mg/kg/day in 2 divided doses 2, 3
- Acute otitis media (with risk factors): 80–90 mg/kg/day in 2 divided doses 3
- Acute bacterial sinusitis (age ≥2 years, no risk factors): 45 mg/kg/day in 2 divided doses 3
- Acute bacterial sinusitis (age <2 years, daycare, or recent antibiotics): 80–90 mg/kg/day in 2 divided doses 3
Risk Factors Requiring High-Dose Pediatric Regimen (90 mg/kg/day):
High-dose amoxicillin is indicated when any of the following are present: 3
- Age <2 years
- Daycare attendance
- Antibiotic use within past 30 days
- Geographic area with >10% penicillin-resistant Streptococcus pneumoniae
- Moderate-to-severe illness at presentation
Neonates and Infants ≤3 Months
The maximum dose for neonates and infants aged 3 months or younger is 30 mg/kg/day divided every 12 hours. 1
Treatment Duration
- Community-acquired pneumonia: 10 days (minimum 48–72 hours after symptom resolution) 3
- Group A Streptococcal pharyngitis: 10 days (full course required to prevent rheumatic fever) 3
- Acute otitis media: 5–10 days depending on age and severity 3
- Acute bacterial sinusitis: Continue for 7 days after symptom resolution, with a minimum total of 10 days 3
Dosing Adjustments for Renal Impairment
For adults with severe renal impairment (GFR <30 mL/min), dose reduction is required. 1
- GFR 10–30 mL/min: 250–500 mg every 12 hours 1
- GFR <10 mL/min: 250–500 mg every 24 hours 1
- Hemodialysis: 250–500 mg every 24 hours, with an additional dose during and after dialysis (amoxicillin half-life on hemodialysis is approximately 3.6 hours) 5
Important caveat: Current dose reductions for renal impairment may lead to subtherapeutic concentrations, especially when targeting less susceptible pathogens with MIC ≥4 mg/L. 6 For serious infections in patients with renal impairment, consider maintaining standard dosing with close monitoring rather than automatic dose reduction. 6
Management of Penicillin Allergy
For Non-Anaphylactic (Non-IgE-Mediated) Reactions:
Second- or third-generation cephalosporins are safe alternatives, as cross-reactivity risk is negligible (<1%). 2, 3
- Cefuroxime axetil: 500 mg twice daily (adults) or 30 mg/kg/day in 2 divided doses (children, maximum 500 mg per dose) 2
- Cefdinir or cefpodoxime are also appropriate alternatives 3
For IgE-Mediated (Type I) Reactions or Anaphylaxis:
Avoid all beta-lactams and use alternative antibiotic classes. 2, 3
- Respiratory infections: Azithromycin 500 mg once daily for 5 days (adults) or 12 mg/kg once daily for 5 days (children, maximum 500 mg) 2, 3
- Respiratory infections (alternative): Levofloxacin 500 mg once daily (adults only, not for children <18 years) 3
- Skin/soft tissue infections: Clindamycin 300–450 mg every 6 hours (adults) or 30–40 mg/kg/day in 3–4 doses (children) 7
Direct Amoxicillin Challenge Without Prior Testing:
For pediatric patients with distant (>5 years ago) benign cutaneous reactions (maculopapular rash or urticaria without systemic symptoms), direct amoxicillin challenge without prior skin testing is recommended. 2
For adults with distant (>5 years ago) benign cutaneous reactions, direct amoxicillin challenge may be considered, though the evidence is less robust than in children. 2
Exclude from direct challenge: Any history of anaphylaxis, angioedema, respiratory symptoms, cardiovascular symptoms, or blistering/exfoliative eruptions. 2
Clinical Monitoring and Expected Response
- Clinical improvement should occur within 48–72 hours of initiating appropriate therapy. 3, 4
- If no improvement or worsening occurs after 48–72 hours, consider: 3
- Treatment failure due to resistant organisms
- Atypical pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae)
- Need for imaging or hospitalization
- Switch to amoxicillin-clavulanate 90 mg/kg/day (amoxicillin component) for beta-lactamase-producing organisms 4
Critical Dosing Pitfalls to Avoid
- Do not underdose children based on outdated guidelines. Current recommendations (45–90 mg/kg/day) reflect contemporary resistance patterns; older British Thoracic Society 2002 recommendations are obsolete. 3
- Do not automatically reduce doses in renal impairment without considering infection severity and pathogen MIC. Standard dose reductions may result in treatment failure for less susceptible organisms. 6
- Do not use first-generation cephalosporins (cephalexin, cefadroxil) as alternatives to amoxicillin for respiratory infections, as they lack activity against Haemophilus influenzae. 2
- Do not prescribe amoxicillin for children weighing ≥40 kg using pediatric weight-based dosing; use adult dosing regimens instead. 3
- Do not discontinue antibiotics early even if symptoms improve; complete the full prescribed course to prevent resistance and recurrence. 3